PubMed · 1977 · 69 citations · 15 references
Life SciencesImmunologyAutoimmunityClinical ImmunologyImmunopathologyAutoantibodiesAutoimmune DiseasesComplement SystemImmune Complex DiseaseSystemic Autoimmune DiseaseSystemic Lupus ErythematosusAnti-double-stranded Deoxyribonucleic Acid Antibody TestingAnti-double-stranded Dna AntibodiesC3 Complement LevelsC4 Complement LevelsComplement Activation AssaysComplement ConsumptionComplement In Autoimmune DiseaseComplement System Abnormalities
Eighty-nine sera from nineteen patients with systemic lupus erythematosus (SLE) have been studied to determine the relationship between levels of DNA-binding activity, complement consumption and evidence of circulating immune complexes. There was a good correlation between the height of DNA binding, a rising C3i and a reciprocal fall in C3, C4 and CH50 levels. These latter measurements provided useful supplemental information when studied serially. There was a good correlation between the results of the various methods used for the detection of circulating immune complexes, and these were found in almost half the sera with DNA binding over 70%. It is concluded that serial studied of DNA binding, complement levels, and direct tests for immune complexes, may provide valuable information in the management of patients with SLE.
15
Measurement of Serum DNA-Binding Activity in Systemic Lupus Erythematosus
Theodore Pincus, Peter H. Schur, James A. Rose et al. · New England Journal of Medicine · 1969 · 449 citations
PLASMAPHERESIS IN THE MANAGEMENT OF ACUTE SYSTEMIC LUPUS ERYTHEMATOSUS?
John Verrier Jones, R C Bucknall, R.H. Gumming et al. · The Lancet · 1976 · 251 citations